Glycated albumin with loss of fatty acid binding capacity contributes to enhanced arachidonate oxygenation and platelet hyperactivity: Relevance in patients with type 2 diabetes

Diabetes

Volumn 64, Issue 3, 2015, Pages 960-972

  Blache, Denis ^a   Bourdon, Emmanuel ^a,c   Salloignon, Pauline ^b   Lucchi, Géraldine ^b   Ducoroy, Patrick ^b   Petit, Jean Michel ^a,b   Verges, Bruno ^a,b   Lagrost, Laurent ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; FATTY ACID; FIBRINOGEN; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; METHYLGLYOXAL; OLEIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; SULFANILAMIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; GLYCOSYLATED SERUM ALBUMIN; PROTEIN BINDING; SERUM ALBUMIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPOALBUMINEMIA; IN VITRO STUDY; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RAT; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; ARACHIDONIC ACID; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PLATELET ACTIVATION; PROTEIN BINDING; SERUM ALBUMIN;

EID: 84928209898     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0879     Document Type: Article

References (64)

1. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703
2. Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001;3:293-311
3. Jalan R, Bernardi M. Effective albumin concentration and cirrhosis mortality: from concept to reality. J Hepatol 2013;59:918-920
4. Luoma PV, Näyhä S, Sikkilä K, Hassi J. High serum alpha-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. J Intern Med 1995;237:49-54
5. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989;2:1434-1436
6. Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke 2004;35:e156-e158
7. Nagumo K, Tanaka M, Chuang VT, et al. Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases. PLoS ONE 2014;9:e85216
8. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005;41:1211-1219
9. Zheng H, Liu J, Liu Y, Klaassen CD. Hepatocytes from metallothionein-I and II knock-out mice are sensitive to cadmium-and tert-butylhydroperoxide-induced cytotoxicity. Toxicol Lett 1996;87:139-145
10. Jouven X, Charles MA, Desnos M, Ducimetière P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001;104:756-761
11. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3-10
12. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-158
13. Ordoñez JD, Hiatt RA, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993;44: 638-642
14. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999;13:233-244
15. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. Diabetes and advanced glycoxidation end products. Diabetes Care 2006;29:1420-1432
16. Gawlowski T, Stratmann B, Stirban AO, Negrean M, Tschoepe D. AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res 2007;121:117-126
17. Gawlowski T, Stratmann B, Ruetter R, et al. Advanced glycation end products strongly activate platelets. Eur J Nutr 2009;48:475-481
18. Cohen MP. Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts. Biochim Biophys Acta 2013;1830:5480-5485
19. Song SO, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis 2012;225:450-455
20. Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007;9:233-245
21. Blache D. Structure and function of blood platelets. Arch Int Physiol Biochim Biophys 1992;100:A17-A24 [in French]
22. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-2494
23. Blache D, Bouthillier D, Davignon J. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis 1992;93:179-188
24. Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996;121: 231-243
25. Schneider M, Vergès B, Klein A, et al. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes 2004;53:2633-2639
26. Zeller M, Masson D, Farnier M, et al. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. J Am Coll Cardiol 2007;50:1948-1955
27. Blache D, Devaux S, Joubert O, et al. Long-term moderate magnesiumdeficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats. Free Radic Biol Med 2006;41:277-284
28. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971;31:87-96
29. Faure P, Wiernsperger N, Polge C, Favier A, Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin Sci (Lond) 2008;114:251-256
30. Blache D, Lussier-Cacan S, Gagnon J, et al. Effect of exercise training on in vitro LDL oxidation and free radical-induced hemolysis: the HERITAGE Family Study. Antioxid Redox Signal 2007;9:123-130
31. Girodon F, Blache D, Monget AL, et al. Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters. J Am Coll Nutr 1997;16: 357-365
32. Sudo T, Ito H, Kimura Y. Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method. Platelets 2003;14:239-246
33. Blache D, Durand P, Prost M, Loreau N. (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo. Free Radic Biol Med 2002;33: 1670-1680
34. Polette A, Blache D. Effect of vitamin E on acute iron load-potentiated aggregation, secretion, calcium uptake and thromboxane biosynthesis in rat platelets. Atherosclerosis 1992;96:171-179
35. Bellavite P, Andrioli G, Guzzo P, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994;216:444-450
36. Eriksson AC, Whiss PA. Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. J Pharmacol Toxicol Methods 2005; 52:356-365
37. Blache D, Gesquière L, Loreau N, Durand P. Oxidant stress: the role of nutrients in cell-lipoprotein interactions. Proc Nutr Soc 1999;58:559-563
38. Bar-Or D, Bar-Or R, Rael LT, Gardner DK, Slone DS, Craun ML. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005;33:1638-1641
39. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85
40. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77
41. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987; 7:135-143
42. Bourdon E, Loreau N, Lagrost L, Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic Res 2005;39:15-20
43. Fang Y, Tong GC, Means GE. Structural changes accompanying human serum albumin's binding of fatty acids are concerted. Biochim Biophys Acta 2006;1764:285-291
44. R Core Team. R: a language for statistical computing. R foundation for Statistical Computing, Vienna, Austria, 2013
45. Lê Cao KA, Rossouw D, Robert-Granié C, Besse P. A sparse PLS for variable selection when integrating omics data. Stat Appl Genet Mol Biol 2008;7:35
46. Wold H. Estimation of principal components and related models by iterarive least squares. In Multivariate Analysis. Krishnaiah P, Ed. New York, Academic Press, 1966, p. 391-420
47. Spector AA. Fatty acid binding to plasma albumin. J Lipid Res 1975;16: 165-179
48. Durand P, Prost M, Blache D. Folic acid deficiency enhances oral contraceptiveinduced platelet hyperactivity. Arterioscler Thromb Vasc Biol 1997;17:1939-1946
49. Gryzunov YA, Arroyo A, Vigne JL, et al. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Arch Biochem Biophys 2003;413:53-66
50. Davì G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005;7:256-268
51. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478
52. Hoak JC. Stearic acid, clotting, and thrombosis. Am J Clin Nutr 1994;60 (Suppl.):1050S-1053S
53. Lafontan M. Advances in adipose tissue metabolism. Int J Obes (Lond) 2008;32(Suppl. 7):S39-S51
54. Doweiko JP, Bistrian BR. The effect of glycosylated albumin on platelet aggregation. JPEN J Parenter Enteral Nutr 1994;18:516-520
55. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318:1315-1321
56. Braschi S, Lagrost L, Florentin E, et al. Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler Thromb Vasc Biol 1996;16:441-449
57. Braschi S, Masson D, Rostoker G, et al. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol 1997;17:2559-2567
58. Pirro M, Mauriège P, Tchernof A, et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Atherosclerosis 2002;160:377-384
59. Carlsson M, Wessman Y, Almgren P, Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 2000;20:1588-1594
60. Makiguchi M, Kawaguchi H, Tamura M, Yasuda H. Effect of palmitic acid and fatty acid binding protein on ventricular fibrillation threshold in the perfused rat heart. Cardiovasc Drugs Ther 1991;5:753-761
61. Pilz S, März W. Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med 2008;46:429-434
62. Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 2007;151:580-590
63. Rubenstein DA, Yin W. Glycated albumin modulates platelet susceptibility to flow induced activation and aggregation. Platelets 2009;20:206-215
64. Yamazaki E, Inagaki M, Kurita O, Inoue T. Kinetics of fatty acid binding ability of glycated human serum albumin. J Biosci 2005;30:475-481